Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Boucher

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Plos One|November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European surveyAndrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
Ebiomedicine|February 13, 2016
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency ReversalMateusz Stoszko, Elisa De Crignis, Casper Rokx, et al.
The Journal of Molecular Diagnostics : JMD|April 20, 2013
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutationsErhard van der Vries, Jeer Anber, Anne van der Linden, et al.
The Lancet Regional Health. Europe|September 24, 2021
Quality of life among people living with HIV in England and the Netherlands: a population-based studyStephanie Popping, Meaghan Kall, Brooke E Nichols, et al.
AIDS Research and Human Retroviruses|August 15, 2018
A Summary of the Third Annual HIV Microbiome WorkshopBrett Williams, Charles Boucher, Frederic Bushman, et al.
The Lancet. HIV|February 5, 2020
Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settingsCheryl Hendrickson, Lawrence Long, David van de Vijver, et al.
Journal of Virological Methods|November 23, 2019
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1Alessia Bertoldi, Vanessa D'Urbano, Isabella Bon, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]Marion P G Koopmans, Adam Meijer, Mariken I M van der Lubben, et al.
The Journal of Infectious Diseases|July 11, 2003
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patientsCarlo Torti, Eugenia Quiros-Roldan, Wilco Keulen, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Plos One|November 22, 2019
Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European surveyAndrea De Luca, Patrizio Pezzotti, Charles Boucher, et al.
Ebiomedicine|February 13, 2016
Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency ReversalMateusz Stoszko, Elisa De Crignis, Casper Rokx, et al.
The Journal of Molecular Diagnostics : JMD|April 20, 2013
Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutationsErhard van der Vries, Jeer Anber, Anne van der Linden, et al.
The Lancet Regional Health. Europe|September 24, 2021
Quality of life among people living with HIV in England and the Netherlands: a population-based studyStephanie Popping, Meaghan Kall, Brooke E Nichols, et al.
AIDS Research and Human Retroviruses|August 15, 2018
A Summary of the Third Annual HIV Microbiome WorkshopBrett Williams, Charles Boucher, Frederic Bushman, et al.
The Lancet. HIV|February 5, 2020
Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settingsCheryl Hendrickson, Lawrence Long, David van de Vijver, et al.
Journal of Virological Methods|November 23, 2019
Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1Alessia Bertoldi, Vanessa D'Urbano, Isabella Bon, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 2009
[Combating the new influenza A (H1N1) virus. I. Overview of the relevant virological aspects]Marion P G Koopmans, Adam Meijer, Mariken I M van der Lubben, et al.
The Journal of Infectious Diseases|July 11, 2003
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patientsCarlo Torti, Eugenia Quiros-Roldan, Wilco Keulen, et al.
Pageof 5